Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase II Trail Evaluating the Efficacy and Safety of GR1802 Injection in Patients with Moderate to Severe Asthma [Phase 2]

View source ↗

Summary

This document provides an update on a Phase II randomized, double-blind, placebo-controlled trial of GR1802 injection for moderate-to-severe asthma, focusing on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GR1802 (GR1802)

Snippet

Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd. | Conditions: Asthma | Phase 2 | Status: UNKNOWN